Technical Analysis for TSHA - Taysha Gene Therapies, Inc.

Grade Last Price % Change Price Change
B 31.74 3.02% 0.93
TSHA closed up 3.02 percent on Monday, January 25, 2021, on 55 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Up Up
Historical TSHA trend table...

Date Alert Name Type % Chg
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Upper Bollinger Band Walk Strength 0.00%
Outside Day Range Expansion 0.00%
Upper Bollinger Band Touch Strength 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup 3.02%
Boomer Buy Setup Bullish Swing Setup 3.02%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 3.02%
NR7 Range Contraction 3.02%
Upper Bollinger Band Walk Strength 3.02%
Older End-of-Day Signals for TSHA ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Boomer Buy Entry about 15 hours ago
Non-ADX 1,2,3,4 Pullback Entry about 15 hours ago
1,2,3, Pullback Entry about 15 hours ago
Rose Above Previous Day's High about 15 hours ago
Rose Above Upper Bollinger Band about 15 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Taysha Gene Therapies, Inc., a gene therapy company, develops adeno-associated virus based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-101 for the treatment of GM2 gangliosidosis; TSHA-118 for the treatment of CLN1 disease; TSHA-102 for the treatment of Rett syndrome; TSHA-103 for the treatment of SLC6A1 haploinsufficiency disorder; and TSHA-104 for the treatment for Surfeit locus 1 deficiency. The company also has strategic partnership with The University of Texas Southwestern Medical Center to develop and commercialize transformative gene therapy treatments. Taysha Gene Therapies, Inc. was founded in 2019 and is based in Dallas, Texas.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Rare Diseases Gene Therapy Lipid Storage Disorders Monogenic University Of Texas Deficiency Gangliosidosis Gm2 Gangliosidoses Gm2 Gangliosidosis Monogenic Diseases

Is TSHA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 33.35
52 Week Low 18.16
Average Volume 139,772
200-Day Moving Average 0.00
50-Day Moving Average 24.15
20-Day Moving Average 28.18
10-Day Moving Average 29.68
Average True Range 2.29
ADX 43.68
+DI 28.13
-DI 6.75
Chandelier Exit (Long, 3 ATRs ) 26.48
Chandelier Exit (Short, 3 ATRs ) 28.75
Upper Bollinger Band 32.23
Lower Bollinger Band 24.13
Percent B (%b) 0.94
BandWidth 28.76
MACD Line 2.08
MACD Signal Line 1.81
MACD Histogram 0.2677
Fundamentals Value
Market Cap 1.2 Billion
Num Shares 37.8 Million
EPS
Price-to-Sales 0.00
Price-to-Book 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 35.12
Resistance 3 (R3) 34.96 33.67 34.55
Resistance 2 (R2) 33.67 32.81 33.75 34.36
Resistance 1 (R1) 32.71 32.28 33.19 32.87 34.18
Pivot Point 31.42 31.42 31.67 31.50 31.42
Support 1 (S1) 30.46 30.56 30.94 30.62 29.30
Support 2 (S2) 29.17 30.03 29.25 29.12
Support 3 (S3) 28.21 29.17 28.93
Support 4 (S4) 28.37